The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice data.

@article{Kievit2007TheEA,
  title={The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice data.},
  author={Wietske Kievit and Eddy M M Adang and Jaap Fransen and Hillechiena H Kuper and Mart A.F.J. van de Laar and Tim L Jansen and C M A De Gendt and D-J de Rooij and Herman L. M. Brus and P C M van Oijen and Piet van Riel},
  journal={Annals of the rheumatic diseases},
  year={2007},
  volume={67 9},
  pages={
          1229-34
        }
}
AIM to evaluate the effects of adalimumab, etanercept and infliximab on disease activity, functional ability and quality of life and the medication costs in a naturalistic design. METHODS All patients from the Dutch Rheumatoid Arthritis Monitoring (DREAM) register starting on tumour necrosis factor (TNF)alpha-blocking agents for the first time were monitored and assessed by trained research nurses every 3 months. The primary outcome was the Disease Activity Score (DAS28) course over the 12… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 62 CITATIONS, ESTIMATED 57% COVERAGE

Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience

Jose Ramon Maneiro, Eva Perez-Pampin, Eva Salgado, Loreto Carmona, Juan J. Gómez-Reino
  • Rheumatology International
  • 2013
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

DOCTOR OF MEDICAL SCIENCE DANISH MEDICAL BULLETIN

VIEW 3 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Treatment strategies in early Rheumatoid Arthritis.

VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients.

  • Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
  • 2019

FILTER CITATIONS BY YEAR

2008
2019

CITATION STATISTICS

  • 4 Highly Influenced Citations

  • Averaged 5 Citations per year from 2017 through 2019